Optogenetic delivery of trophic signals in a genetic model of Parkinson's disease
- PMID: 33857132
- PMCID: PMC8049241
- DOI: 10.1371/journal.pgen.1009479
Optogenetic delivery of trophic signals in a genetic model of Parkinson's disease
Abstract
Optogenetics has been harnessed to shed new mechanistic light on current and future therapeutic strategies. This has been to date achieved by the regulation of ion flow and electrical signals in neuronal cells and neural circuits that are known to be affected by disease. In contrast, the optogenetic delivery of trophic biochemical signals, which support cell survival and are implicated in degenerative disorders, has never been demonstrated in an animal model of disease. Here, we reengineered the human and Drosophila melanogaster REarranged during Transfection (hRET and dRET) receptors to be activated by light, creating one-component optogenetic tools termed Opto-hRET and Opto-dRET. Upon blue light stimulation, these receptors robustly induced the MAPK/ERK proliferative signaling pathway in cultured cells. In PINK1B9 flies that exhibit loss of PTEN-induced putative kinase 1 (PINK1), a kinase associated with familial Parkinson's disease (PD), light activation of Opto-dRET suppressed mitochondrial defects, tissue degeneration and behavioral deficits. In human cells with PINK1 loss-of-function, mitochondrial fragmentation was rescued using Opto-dRET via the PI3K/NF-кB pathway. Our results demonstrate that a light-activated receptor can ameliorate disease hallmarks in a genetic model of PD. The optogenetic delivery of trophic signals is cell type-specific and reversible and thus has the potential to inspire novel strategies towards a spatio-temporal regulation of tissue repair.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures
![Fig 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8049241/bin/pgen.1009479.g001.gif)
![Fig 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8049241/bin/pgen.1009479.g002.gif)
![Fig 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8049241/bin/pgen.1009479.g003.gif)
![Fig 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8049241/bin/pgen.1009479.g004.gif)
![Fig 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8049241/bin/pgen.1009479.g005.gif)
Similar articles
-
Ginseng protein protects against mitochondrial dysfunction and neurodegeneration by inducing mitochondrial unfolded protein response in Drosophila melanogaster PINK1 model of Parkinson's disease.J Ethnopharmacol. 2020 Jan 30;247:112213. doi: 10.1016/j.jep.2019.112213. Epub 2019 Sep 25. J Ethnopharmacol. 2020. PMID: 31562951
-
The Importance of Drosophila melanogaster Research to UnCover Cellular Pathways Underlying Parkinson's Disease.Cells. 2021 Mar 6;10(3):579. doi: 10.3390/cells10030579. Cells. 2021. PMID: 33800736 Free PMC article. Review.
-
Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin.Nature. 2006 Jun 29;441(7097):1162-6. doi: 10.1038/nature04779. Epub 2006 May 3. Nature. 2006. PMID: 16672981
-
PINK1-mediated phosphorylation of Miro inhibits synaptic growth and protects dopaminergic neurons in Drosophila.Sci Rep. 2014 Nov 7;4:6962. doi: 10.1038/srep06962. Sci Rep. 2014. PMID: 25376463 Free PMC article.
-
What have we learned from Drosophila models of Parkinson's disease?Prog Brain Res. 2010;184:3-16. doi: 10.1016/S0079-6123(10)84001-4. Prog Brain Res. 2010. PMID: 20887867 Review.
Cited by
-
Invertebrate genetic models of amyotrophic lateral sclerosis.Front Mol Neurosci. 2024 Mar 4;17:1328578. doi: 10.3389/fnmol.2024.1328578. eCollection 2024. Front Mol Neurosci. 2024. PMID: 38500677 Free PMC article. Review.
-
Optimized design and in vivo application of optogenetically functionalized Drosophila dopamine receptors.Nat Commun. 2023 Dec 19;14(1):8434. doi: 10.1038/s41467-023-43970-0. Nat Commun. 2023. PMID: 38114457 Free PMC article.
-
Optogenetic dissection of RET signaling reveals robust activation of ERK and enhanced filopodia-like protrusions of regenerating axons.Mol Brain. 2023 Jul 4;16(1):56. doi: 10.1186/s13041-023-01046-6. Mol Brain. 2023. PMID: 37403137 Free PMC article.
-
Regenerative Strategies for Retinal Neurons: Novel Insights in Non-Mammalian Model Organisms.Int J Mol Sci. 2022 Jul 25;23(15):8180. doi: 10.3390/ijms23158180. Int J Mol Sci. 2022. PMID: 35897754 Free PMC article. Review.
-
Optogenetic neuroregeneration.Neural Regen Res. 2022 Jul;17(7):1468-1470. doi: 10.4103/1673-5374.330596. Neural Regen Res. 2022. PMID: 34916420 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous